Body-mass index may misclassify obesity for a meaningful share of people, according to a new international study published in Nature. ScienceAlert reported that the researchers compared BMI with a broader definition of obesity proposed by experts in 2025 and concluded that millions of people worldwide could be misdiagnosed.
The new framework also separates obesity that is already damaging the body from obesity that has not yet caused harm, a distinction the study linked to very different risks of dying.
BMI divides a person’s weight by their height squared. ScienceAlert noted that it has long been seen as too approximate. The 2025 framework takes in other measurements, including waist circumference, waist-to-height ratio and body fat scans. It also looks for signs of organ damage or physical impairment that affects everyday activities.
Under the framework, clinical obesity is a condition in which excess fat is damaging internal systems and organs. Preclinical obesity means a person has excess weight that has not yet begun to harm how the body works.
The difference showed up clearly in outcomes. Clinical obesity was associated with a 69 percent higher risk of dying over follow-up periods of more than a decade, versus 19 percent for preclinical obesity. ScienceAlert noted that traditional diagnosis would not flag that gap.
Rubino said most people with preclinical obesity, though not all, remained free of clinical obesity for a decade. He said preclinical obesity should be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, he said, but its intensity should match their individual risk.
The report said researchers hope that, if doctors and health care professionals adopt the proposals more widely, treatments such as GLP-1 weight loss drugs can go to people who really need them, rather than to everyone classified as obese under BMI rules.
Epidemiologist An Pan of Huazhong University of Science and Technology in China said the differences in prognosis were consistent across countries and ethnic groups. In his view, that supports adopting the new framework globally to improve obesity care and policy.
The team plans further studies on how to apply the new criteria effectively and on refining the diagnostic techniques to make them more accurate. Future research could also examine how treatments affect the health of people with clinical and preclinical obesity.
The findings could help research in other areas of health, too, such as working out whether heart disease was brought on by obesity or by something else. Rubino said that getting the scope of care right, whether treating existing disease or reducing risk, matters both for the billion-plus people affected and for health care systems.
Around Prague, based on reporting by ScienceAlert